Description
Description
Deproteinized Calf Blood Extractives, is a drug that improves the energy metabolism of cells, has aroused a wide concern at home and abroad after years of clinical application because of its prominent curative effect on the nervous system. At present, the clinical applications mainly include cerebral and nervous system diseases, vascular diseases, ulcer diseases and burns.
According to CRI’s research, the global growth of patented nervous system drugs is slowing down. The drugs used to treat cranial nerve and cerebral circulation systems are experiencing a market downturn. However, the market performance is quite different in China. In recent years, the drug demand from neurology departments of Chinese hospitals is growing continuously with the rapid development of the pathogenesis of common neurological diseases and clinical pharmacology. Deproteinized Calf Blood Extractives is a big variety and a pillar nervous system drug in clinical applications in China.
According to CRI’s research, the sales value of Deproteinized Calf Blood Extractives reached CNY146.45 million in 2019, the CAGR was -24.7% in 2015 to 2019. In recent years, the main reason for the decline in sales of Deproteinized Calf Blood Extractives in the Chinese market is the continuous decline in sales of injections, and the sales of other dosage forms have an upward trend. The market was dominated by Shenyang Xingqi Pharmaceutical Co., Ltd., Harbin Sanctity Pharmaceutical Co., Ltd., Jilin Connell Pharmaceutical Co., Ltd., Wuhan Humanwell Pharmaceutical Co., Ltd., etc., with CR5 reaching over 90%. Shenyang Xingqi Pharmaceutical Co., Ltd. captured the biggest market share, whose market share exceeded 28.2% by sales value in 2019.
According to CRI’s research, the sales of Deproteinized Calf Blood Extractives injections in the Chinese market are showing a declining trend, but the sales of other dosage forms, such as gels, are rising rapidly. It is expected that the overall sales of Deproteinized Calf Blood Extractives in China may rebound in the next few years.
Topics Covered:
-Development environment of the Chinese Deproteinized Calf Blood Extractives market
-Market Size of the Chinese Deproteinized Calf Blood Extractives market 2015-2019
-Market Size of Deproteinized Calf Blood Extractives by regions in China 2015-2019
-Market Share of major manufacturers of Deproteinized Calf Blood Extractives in China 2015-2019
-Prices of major manufacturers of Deproteinized Calf Blood Extractives in China 2019-2020
-Forecast on the Chinese Deproteinized Calf Blood Extractives market 2020-2024
